Parag Milk Foods Limited (PARAGMILK.NS)
INR 197.58
(-0.54%)
INR 197.58
(-0.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 297.38 Million | -1.94 Billion | -1.48 Billion | 999.52 Million | -663.95 Million | 1.4 Billion |
| Net Income | 905.83 Million | 510.62 Million | -5.22 Billion | 407.24 Million | 1.26 Billion | 1.47 Billion |
| Depreciation & Amortization | 602.53 Million | 572.75 Million | 537.44 Million | 517.98 Million | 536.41 Million | 501.85 Million |
| Deferred income taxes | - | - | 207.05 Million | -102.87 Million | -239.3 Million | 268 Million |
| Stock-based compensation | - | - | -7.29 Million | -980 Thousand | 3.38 Million | 4.89 Million |
| Change in working capital | -1.07 Billion | -3.33 Billion | 2.64 Billion | -193.42 Million | -2.54 Billion | -1.13 Billion |
| Other non-cash items | 2.14 Billion | 308.48 Million | 345.39 Million | 371.57 Million | 315.92 Million | 281.7 Million |
| Investing Cash Flow | -560.84 Million | -894.2 Million | -260.16 Million | -468.31 Million | -294.98 Million | -701.42 Million |
| Investments in PPE | -611.85 Million | -609.22 Million | -356.75 Million | -443.55 Million | -318.16 Million | -854.93 Million |
| Acquisitions | 5.79 Million | 74.5 Million | 4 Million | 13.09 Million | 6.92 Million | 15.48 Million |
| Investment purchases | -46.25 Million | -364.67 Million | -4 Million | -65.81 Million | -10 Thousand | -1 Million |
| Sales/Maturities of investments | 91.47 Million | 10 Thousand | 77.75 Million | -13.09 Million | 2.08 Million | 129.38 Million |
| Other Investing Activities | 5.64 Million | 5.18 Million | 18.84 Million | 41.05 Million | 14.19 Million | 9.65 Million |
| Financing Cash Flow | 231.06 Million | 2.17 Billion | 2.47 Billion | -685.54 Million | 1.1 Billion | -936.91 Million |
| Debt repayment | -195.03 Million | -694.3 Million | -875.21 Million | -143.84 Million | -197.35 Million | -277.46 Million |
| Dividends payments | - | - | -47.69 Million | -42.06 Million | -101.41 Million | -76.05 Million |
| Common Stock Repurchased | - | - | 875.21 Million | - | - | 247.78 Million |
| Common Stock Issuance | 140.61 Million | 1.79 Billion | 3.87 Billion | - | - | 12.74 Million |
| Other Financing Activities | 10 Thousand | 1.07 Billion | -1.35 Billion | -499.64 Million | 1.4 Billion | -843.92 Million |
| Accounts receivables | -1.32 Billion | 354.98 Million | 1.06 Billion | 300.2 Million | -802.55 Million | -704.69 Million |
| Accounts payables | 678.63 Million | 321.4 Million | -574.04 Million | 120.52 Million | -47.76 Million | -62.54 Million |
| Inventory | -417.67 Million | -948.15 Million | 2.16 Billion | -618.99 Million | -1.7 Billion | -249.45 Million |
| Other working capital | -10.46 Million | -3.06 Billion | -7.72 Million | 4.85 Million | 460 Thousand | -115.84 Million |
| Cash at beginning of period | 137.99 Million | 796.73 Million | 69.45 Million | 223.78 Million | 73.46 Million | 310.01 Million |
| Cash at end of period | 275.74 Million | 137.98 Million | 796.73 Million | 69.45 Million | 223.78 Million | 73.46 Million |
| Capital Expenditure | -611.85 Million | -609.22 Million | -356.75 Million | -443.55 Million | -318.16 Million | -854.93 Million |
| Effect of forex changes on cash | - | 3.96 Billion | - | - | - | - |
| Net cash flow / Change in cash | 137.75 Million | -658.75 Million | 727.28 Million | -154.33 Million | 150.32 Million | -236.55 Million |
| Free Cash Flow | -314.47 Million | -2.54 Billion | -1.84 Billion | 555.97 Million | -982.11 Million | 546.85 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 273 Million | 905.83 Million | 98.13 Million | 341.65 Million | 251.88 Million | 214.17 Million |
| Depreciation & Amortization | - | 602.53 Million | - | 154.29 Million | 154.77 Million | 147.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -1.07 Billion | - | - | - | - |
| Other non-cash items | -273 Million | 2.14 Billion | -98.13 Million | -341.65 Million | -251.88 Million | -214.17 Million |
| Investing Cash Flow | - | -560.84 Million | - | - | - | - |
| Investments in PPE | - | -611.85 Million | - | - | - | - |
| Acquisitions | - | 5.79 Million | - | - | - | - |
| Investment purchases | - | -46.25 Million | - | - | - | - |
| Sales/Maturities of investments | - | 91.47 Million | - | - | - | - |
| Other Investing Activities | - | 5.64 Million | - | - | - | - |
| Financing Cash Flow | - | 231.06 Million | - | - | - | - |
| Debt repayment | - | -195.03 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 140.61 Million | - | - | - | - |
| Other Financing Activities | - | 10 Thousand | - | - | - | - |
| Accounts receivables | - | -1.32 Billion | - | - | - | - |
| Accounts payables | - | 678.63 Million | - | - | - | - |
| Inventory | - | -417.67 Million | - | - | - | - |
| Other working capital | - | -10.46 Million | - | - | - | - |
| Cash at beginning of period | - | 137.99 Million | - | 126.5 Million | -183.04 Million | 137.99 Million |
| Cash at end of period | - | 275.74 Million | - | 435.08 Million | 126.5 Million | 433.29 Million |
| Capital Expenditure | - | -611.85 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 137.75 Million | - | 308.58 Million | 309.54 Million | 295.3 Million |
| Free Cash Flow | - | -314.47 Million | - | 308.58 Million | 309.54 Million | 295.3 Million |
BIOFILCHEM
CROISSANCE
MSIU
DCMNVL
TWRKF
BGIP3